Senseonics Holdings, Inc.

Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor

Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference